Teva Pharmaceutical Industries Ltd. ADR
[WKN: 883035 | ISIN: US8816242098] Aktienkurse
11,039$ -0,63%
Echtzeit-Aktienkurs Teva Pharmaceutical Industries Ltd. ADR
Bid: 11,016$ Ask: 11,063$

Reuters Kategorien
dpa-AFX Compact / dpa-AFX PRO Kategorien
10.02.2021 um 14:00 Uhr

Tevas stock rallies 2% on earnings

Shares of Teva Pharmaceutical Industries Ltd. gained 2.7% in premarket trading on Wednesday after the drugmaker beat expectations for…
10.02.2021 um 13:25 Uhr

Recap: Teva Pharmaceutical Q4 Earnings

  Shares of Teva Pharmaceutical Indus (NYSE:TEVA) moved higher by 3.7% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings…
21.12.2020 um 17:20 Uhr

TEVA Pharmaceutical: "Best Idea for 2021"

Rye (www.aktiencheck.de) - Rating-Update: Kevin Kedra, Analyst von Gabelli & Company, wählt die Aktie des Biotechkonzerns TEVA Pharmaceutical Industries Ltd. (ISIN:…
16.12.2020 um 16:10 Uhr

IBI sees 50% upside in Teva

IBI analyst Steven Tepper sees a leaner and more efficient Teva returning to growth in 2021....…
20.11.2020 um 03:50 Uhr

TEVA SHAREHOLDER NOTICE

Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva To Contact Him Directly To Discuss…
19.11.2020 um 03:45 Uhr

Teva Shareholder Alert

Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva To Contact Him Directly To Discuss…
18.11.2020 um 03:00 Uhr

Teva Deadline Alert

Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva To Contact Him Directly To Discuss…
15.11.2020 um 17:00 Uhr

Teva Lead Plaintiff Deadline Alert

Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva To Contact Him Directly To Discuss…
15.11.2020 um 11:10 Uhr

EU opens Teva antitrust probe

According to a report by Reuters, the investigation relates to Tevas multiple sclerosis treatment Copaxone....…
Hinweis: Die veröffentlichten Tradingsignale und Empfehlungen dienen lediglich der allgemeinen Information, sie sind keine Beratung im Sinne des Wertpapierhandelsgesetzes und stellen kein Angebot und keine Aufforderung zum Kauf, Halten oder Verkauf von Wertpapieren oder Derivaten dar. Sie entsprechen lediglich der aktuellen Einschätzung des verwendeten Handelssystems.
TraderFox GmbH: Impressum & Datenschutz - Allgemeine Geschäftsbedingungen - Cookie-Erklärung